Covid Variant XBB.1.5 Accounts for 41% of New US Cases; Can Resist Antibodies, Challenge Vaccines

Covid Variant XBB.1.5 Accounts for 41% of New US Cases; Can Resist Antibodies, Challenge Vaccines https://ift.tt/ClbFoy7